Project Grant K01HL179246
- The National Heart, Lung, and Blood Institute awarded The Regents of the University of Colorado (University of Colorado-Denver) $163,285 on July 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support a five-year career development project studying the intersection of cardiovascular disease and cancer. The award funds research investigating how colon cancer mediates arterial remodeling through smooth muscle cell phenotypic changes via PDGFR-B signaling. The project...
- The National Heart, Lung, and Blood Institute awarded $338,934 to The Regents of the University of Colorado, doing business as University of Colorado-Denver, on September 18, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) for a K01 mentored career development award titled "Start Strong: A Mixed Methods Study to Inform Initial Antihypertensive Prescribing and a Patient-Self Titration Intervention to Improve Blood Pressure Control, Safety, and Reduce Cardiovascular...
- The National Heart, Lung, and Blood Institute awarded the University of Denver $169,638 on July 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate neighborhood food access as a predictor of cardiovascular disease risk in early childhood. The project applies a prospective mechanistic approach to test whether limited neighborhood food access associates with obesogenic food-related behaviors and higher cardiovascular disease risk in early childhood. The...
- The National Heart, Lung, and Blood Institute awarded The Regents Of The University Of Colorado (University of Colorado-Denver) $169,225 on July 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support a K23 career development grant. The award funds Dr. Rochelle Cason-Wilkerson's research into targeted intervention and process strategies (TIPS) to enhance health outcomes and reduce attrition in preschool-aged children with obesity. The research adapts an existing...
- The National Heart, Lung, and Blood Institute awarded The Regents of the University of Colorado (University of Colorado-Denver) $168,691 on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to refine, augment, and pilot test an affect-based physical activity promotion program for cancer survivors at elevated risk of cardiovascular disease. The award funds a K01 Career Development Award with a five-year period of performance through July 31, 2031. Work is...
- The National Institutes of Health National Heart Lung and Blood Institute awarded $150,104 to The Regents Of The University Of Colorado (University of Colorado-Denver) on January 26, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) for a Project Grant (F32HL179804) to investigate lysine myristoylation as a regulatory mechanism for protein kinase A (PKA) in cardiac tissue. The award funds research examining how histone deacetylase 11 (HDAC11) inhibition increases PKA...
- The National Heart, Lung, and Blood Institute awarded The Regents Of The University Of Colorado, doing business as University Of Colorado-Denver, $249,000 on February 16, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate the biogenesis of HERG1a/1b ion channels in cardiomyocyte models. The recipient will define mRNA structural features that promote co-translational assembly of HERG1a and 1b subunits, which together conduct the cardiac repolarizing potassium...
- The National Heart, Lung, and Blood Institute awarded The Regents of the University of Colorado, doing business as University of Colorado-Denver, $624,789 on June 5, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop prenatal diagnosis methods for coarctation of the aorta using cardiac magnetic resonance imaging. The project addresses the high false positive rate of fetal echocardiography in detecting coarctation of the aorta, a severe congenital narrowing of the...
- The National Heart, Lung, and Blood Institute awarded The Regents of the University of Colorado (University of Colorado-Denver) $1,357,964 on August 24, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to discover prognostic biomarkers of early pulmonary fibrosis and develop secondary prevention strategies. The research identifies genetic, molecular, and environmental biomarkers that trigger and predict progression of fibrotic interstitial lung abnormalities (FILAs)...
- The National Heart, Lung, and Blood Institute awarded The Regents of the University of Colorado, doing business as University of Colorado-Denver, $212,782 on September 9, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate developmental dysanapsis in lung development throughout the lifespan in experimental bronchopulmonary dysplasia. The research examines whether intra-amniotic endotoxin causes persistent dysanaptic growth of airways, distal parenchyma, and...
The National Heart, Lung, and Blood Institute awarded The Regents Of The University Of Colorado (University of Colorado–Denver) $161,583 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to support Dr. Curtis Tilves's transition to an independent scientist through mentored research training. Tilves, a research associate at the LifeCourse Epidemiology of Adiposity and Diabetes (LEAD) Center at University of Colorado Anschutz Medical Campus, will develop expertise in conducting and analyzing clinical trials, generating and processing multi-omics data, and applying machine learning to integrate multiple omics measurements. His research leverages plant food genomics and multi-omics analysis to objectively characterize adherence to the DASH diet and quantify plant food diversity, then uses these biomarkers to understand the cardiovascular health impact of dietary approaches. The work addresses the limitation that epidemiologic evidence on healthy dietary patterns relies heavily on self-reported dietary intake, which carries substantial measurement error and systematic bias. Objective dietary biomarkers derived from residual plant food genomics in feces may provide more specific measures than existing high-dimensional omics datasets such as microbiome or metabolome data. This is a Project Grant, classified as a K01 award—a career development grant supporting mentored research training. Performance runs through June 30, 2031, at Aurora, Colorado.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $161.6k | 9/1/26 |